|
Volumn 25, Issue 1, 2009, Pages 103-114
|
Safety and immunogenicity of adenovirus-vectored near-consensus HIV type 1 clade B gag vaccines in healthy adults.
a a a a a a a a a a a a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
GAG PROTEIN;
HUMAN IMMUNODEFICIENCY VIRUS VACCINE;
PLACEBO;
ADENOVIRUS;
ADOLESCENT;
ADULT;
ANIMAL;
ARTICLE;
CELL CULTURE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
FEMALE;
GENE VECTOR;
GENETICS;
HUMAN;
HUMAN EXPERIMENT;
HUMAN IMMUNODEFICIENCY VIRUS 1;
IMMUNIZATION;
IMMUNOLOGY;
INTRAMUSCULAR DRUG ADMINISTRATION;
MALE;
MIDDLE AGED;
MONONUCLEAR CELL;
MULTICENTER STUDY;
PHASE 1 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
ADENOVIRIDAE;
ADOLESCENT;
ADULT;
AIDS VACCINES;
ANIMALS;
CELLS, CULTURED;
DOUBLE-BLIND METHOD;
FEMALE;
GAG GENE PRODUCTS, HUMAN IMMUNODEFICIENCY VIRUS;
GENETIC VECTORS;
HIV-1;
HUMAN EXPERIMENTATION;
HUMANS;
IMMUNIZATION, SECONDARY;
INJECTIONS, INTRAMUSCULAR;
LEUKOCYTES, MONONUCLEAR;
MALE;
MIDDLE AGED;
PLACEBOS;
|
EID: 60549106905
PISSN: None
EISSN: 19318405
Source Type: Journal
DOI: 10.1089/aid.2008.0212 Document Type: Article |
Times cited : (62)
|
References (0)
|